Treatment Updates
  • Featured content
    Expert faculty review key data informing the optimal use of contemporary HIV treatment across settings, including first-line treatment, antiretroviral therapy (ART) modification in virologically suppressed patients or those experiencing virologic failure, treatment as prevention, managing ART in the context of common comorbidities, or ART in patients with viral hepatitis coinfection.
  • Featured content
    In these 3 modules from inPractice, experts review best practices and recent guidelines for ART selection and management in the first-line setting and when switching regimens in patients with virologic suppression. In addition, expert guidance, recommendations, and key considerations for managing HIV infection in women are provided. Each module includes concise summaries of key clinical data and implications of those data for clinical practice.
  • Featured content
    Danielle Ciuffetelli, PharmD, and Elly Fatehi, PharmD, BCPS, review important considerations when selecting initial ART and explore how formularies can be better managed to ensure delivery of optimal care for diverse populations of HIV-infected patients. Illustrative cases provide useful examples of key factors involved in treatment selection.
  • Featured content
    Virtual presentation and downloadable slides covering clinical trial data on optimal ART management.
  • Featured content
    In this program, which includes downloadable slides and audio, Jürgen K. Rockstroh, MD, provides expert perspectives on how drug–drug interactions and differing antiretroviral genetic barriers to resistance can influence selection of antiretroviral therapy.
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Programs

10 of 81 Shown
  • Expert faculty review key data informing the optimal use of contemporary HIV treatment across settings, including first-line treatment, antiretroviral therapy (ART) modification in virologically suppressed patients or those experiencing virologic failure, treatment as prevention, managing ART in the context of common comorbidities, or ART in patients with viral hepatitis coinfection.

    Contemporary Management of HIV

    Expert faculty review key data informing the optimal use of contemporary HIV treatment across settings, including first-line treatment, antiretroviral therapy (ART) modification in virologically suppressed patients or those experiencing virologic failure, treatment as prevention, managing ART in the context of common comorbidities, or ART in patients with viral hepatitis coinfection.
    Date Posted: 1/20/2017
  • In these 3 modules from inPractice, experts review best practices and recent guidelines for ART selection and management in the first-line setting and when switching regimens in patients with virologic suppression. In addition, expert guidance, recommendations, and key considerations for managing HIV infection in women are provided. Each module includes concise summaries of key clinical data and implications of those data for clinical practice.

    Clinical Resources From inPractice HIV

    In these 3 modules from inPractice, experts review best practices and recent guidelines for ART selection and management in the first-line setting and when switching regimens in patients with virologic suppression. In addition, expert guidance, recommendations, and key considerations for managing HIV infection in women are provided. Each module includes concise summaries of key clinical data and implications of those data for clinical practice.
    Date Posted: 1/20/2017
  • Danielle Ciuffetelli, PharmD, and Elly Fatehi, PharmD, BCPS, review important considerations when selecting initial ART and explore how formularies can be better managed to ensure delivery of optimal care for diverse populations of HIV-infected patients. Illustrative cases provide useful examples of key factors involved in treatment selection.

    Antiretroviral Therapy 2016-2017: The Continuing Need for Individualized Therapy to Optimize Outcomes Among Diverse HIV Patients

    Danielle Ciuffetelli, PharmD, and Elly Fatehi, PharmD, BCPS, review important considerations when selecting initial ART and explore how formularies can be better managed to ensure delivery of optimal care for diverse populations of HIV-infected patients. Illustrative cases provide useful examples of key factors involved in treatment selection.
    Date Posted: 1/10/2017
  • Virtual presentation and downloadable slides covering clinical trial data on optimal ART management.

    ART Under Pressure: Comparing Regimens in Challenging Clinical Scenarios

    Virtual presentation and downloadable slides covering clinical trial data on optimal ART management.
    Date Posted: 11/11/2016
  • In this program, which includes downloadable slides and audio, Jürgen K. Rockstroh, MD, provides expert perspectives on how drug–drug interactions and differing antiretroviral genetic barriers to resistance can influence selection of antiretroviral therapy.

    Choosing Among Current Antiretroviral Regimens: The Relevance of Drug–Drug Interactions and Barrier to Resistance

    In this program, which includes downloadable slides and audio, Jürgen K. Rockstroh, MD, provides expert perspectives on how drug–drug interactions and differing antiretroviral genetic barriers to resistance can influence selection of antiretroviral therapy.
    Date Posted: 11/4/2016
  • Online presentation and downloadable slides covering current challenges and potential solutions related to HIV prevention and ART delivery for women globally and within resource-limited settings.

    HIV Infection Among Women: Strategies to Address 3 Key Global Challenges

    Online presentation and downloadable slides covering current challenges and potential solutions related to HIV prevention and ART delivery for women globally and within resource-limited settings.
    Date Posted: 7/8/2016
  • A yearlong series of live Webinars in which expert faculty review key data and provide perspectives on the impact of new developments in HIV care.

    HIV Alerts: A Webinar Series on Key Updates in HIV Management

    A yearlong series of live Webinars in which expert faculty review key data and provide perspectives on the impact of new developments in HIV care.
    Date Posted: 5/12/2016
  • click here to access the downloadable slidesets." alt="This content has moved. Please click here to access the downloadable slidesets." src="/~/media/HIV/Programs/Contemporary Management of HIV/2016_ViiV_DM_Series_Icon_IMG.ashx" />

    Contemporary Management of HIV

    This content has moved. Please click here to access the downloadable slidesets.
    Date Posted: 2/9/2016
  • Experts highlight the latest guidance and clinical data informing the optimal selection of first-line ART and ART switching in virologically suppressed patients and those with virologic failure.

    Best Practices in Antiretroviral Therapy

    Experts highlight the latest guidance and clinical data informing the optimal selection of first-line ART and ART switching in virologically suppressed patients and those with virologic failure.
    Date Posted: 12/11/2015
  • In this CME-certified interactive presentation, José R. Arribas, MD, and Hans-Jüurgen Stellbrink, MD, review essential considerations for providing first-line antiretroviral therapy to older HIV patients.

    Choosing and Using First-line Antiretroviral Therapy in Older Patients

    In this CME-certified interactive presentation, José R. Arribas, MD, and Hans-Jüurgen Stellbrink, MD, review essential considerations for providing first-line antiretroviral therapy to older HIV patients.
    Date Posted: 9/4/2015
10 of 81 Shown
Show 10 More
Loading...